Association of β-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS)

American Heart Journal

Volumn 150, Issue 3, 2005, Pages 464-470

  Chan, Jeannie D ^a,e   Rea, Thomas D ^a   Smith, Nicholas L ^a   Siscovick, David ^a   Heckbert, Susan R ^a   Lumley, Thomas ^a   Chaves, Paulo ^b   Furberg, Curt D ^c   Kuller, Lewis ^d   Psaty, Bruce M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; LABETALOL; METOPROLOL; NADOLOL; PROPRANOLOL DERIVATIVE; TIMOLOL;

AGED; ARTICLE; CAUSE OF DEATH; CLINICAL OBSERVATION; CLINICAL TRIAL; COMMUNITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SENESCENCE; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE;

EID: 24944441753     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.022     Document Type: Article

References (22)

1. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitors Trials JAMA 273 1995 1450 1456
2. M.R. Bristow Beta-adrenergic receptors blockade in chronic heart failure Circulation 101 2000 558 569
3. J.M. Foody, M.H. Farrell, and H.M. Krumholz Beta-blocker therapy in heart failure: Scientific review JAMA 287 2002 883 889
4. M.M. Redfield, S.J. Jacobsen, and J.C. Burnett Jr. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
5. C. Zhan, J. Sangl, and A. Bierman Potentially inappropriate medication use in community-dwelling elderly: Findings from the 1996 medical expenditure panel survey JAMA 286 2001 2823 2829
6. L.P. Fried, N.O. Borhani, and P. Enright The Cardiovascular Health Study: Design and rationale Ann Epidemiol 1 1991 263 276
7. G.S. Tell, L.P. Fried, and B. Hermanson Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study Ann Epidemiol 3 1993 358 366
8. B.M. Psaty, L.H. Kuller, and D. Bild Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study Ann Epidemiol 5 1995 270 277
9. D.G. Ives, A.L. Fitzpatrick, and D. Bild Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study Ann Epidemiol 5 1995 278 285
10. B.M. Psaty, M. Lee, and P.J. Savage Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group J Clin Epidemiol 45 1992 683 692
11. N.L. Smith, B.M. Psaty, and S.R. Heckbert The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly J Clin Epidemiol 52 1999 143 146
12. P.A. Poole-Wilson, K. Swedberg, and J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomized controlled trial Lancet 362 2003 7 13
13. H.J. Dargie β-Blockers in heart failure: Commentary Lancet 362 2003 2 3
14. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved trial Lancet 362 2003 777 781
15. BEST Investigators A trial of the beta blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
16. P. Carson, S. Ziesche, and G. Johnson Racial differences in patients with heart failure: Analysis of the vasodilator heart failure trials J Card Fail 5 1999 178 187
17. D.V. Exner, D.L. Dries, and M.J. Domanski Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction N Engl J Med 344 2001 1351 1357
18. D.L. Dries, D.V. Exner, and B.J. Gersh Racial differences in the outcome of left ventricular dysfunction N Engl J Med 340 1999 609 616
19. A.L. Taylor, S. Ziesche, and C. Yancy Combination of isosorbide dinitrite and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
20. R.A. Preston, B.J. Materson, and D.J. Reda Age-race subgroup compared with renin profile as predictors of blood pressure response to anti-hypertensive therapy JAMA 280 1998 1168 1172
21. E. Saunders, M.R. Weir, and B.W. Kong A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks Arch Intern Med 150 1990 1707 1712
22. P.G. Shekelle, M.W. Rich, and S.C. Morton Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529 1538